Egis Pharmaceuticals PLC acquired Sinuforte from Hartington Business S.L. Under the agreement Egis receives all rights related to the product, a nasal spray indicated for the treatment of sinusitis and other inflammatory diseases of the paranasal sinuses. The company seeks to ensure its growing presence in major export markets through organic growth and targeted acquisitions.
Egis Pharmaceuticals expands portfolio thus improves Russian people’s access to its high quality, EU manufactured therapies.
EGIS-RUS received the honor from Aon Hewitt, the global leader in human resource solutions and its Russian partner AXES Management
EGIS-RUS LLC made rebranding of the popular skin repair products: D-Panthenol Novatenol (cream and ointment) took place D-Panthenol (cream and ointment) on pharmacy shelves.
Hungarian-based Egis Pharmaceuticals PLC launch in Russia the first fixed drug combination of two lipid-lowering agents: rosuvastatin and ezetimibe.
New Year is a time of miracles and cherished wishes, it is essentially about and for children. Therefore, EGIS-RUS decided to give them a charity Christmas Tree “Chain of Good”. On December 21, 2019, EGIS-RUS’ office opened its doors for the children of the employees and young guests from the orphanage in Moscow.
Egis Russia’s Buy for Good campaign that was carried out in 2018 won the award of ‘Best Social Projects in Russia’ in the category of medical and social projects.
November 21, 2019: A symposium “New opportunities for reducing cardiovascular risk in the Russian Federation”, organized by EGIS-RUS, was held in the frame of the XIV National Congress of Therapists.
From October 7 to December 22, 2019, there will be a TV broadcasting campaign in support of Sinuforte®. The commercial under the slogan “Do not let sinusitis cling on to you” is broadcasting on the largest federal television channels: Russia, TNT, Muz-TV, Friday, Channel 5, TV-3, Disney, U.